Advertisement
Screener

Pulse Biosciences, Inc. (PLSE) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

2.3 / 5 stars · 21/45 Roast Me

Pulse Biosciences, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

Pulse Biosciences, Inc. (PLSE) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 12.40 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06

  • Pulse Biosciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 11.54M shares, a 15.91% decline year-over-year.
  • Pulse Biosciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 13.73M shares, a 35.98% increase year-over-year.
  • Pulse Biosciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 10.10M shares, a 21.22% decline year-over-year.
  • Pulse Biosciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 12.82M shares, a 130.56% increase year-over-year.
  • Pulse Biosciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 13.35M shares, a 6.71% increase from fiscal 2024.
  • Pulse Biosciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 12.51M shares, a 32.13% increase from fiscal 2023.
  • Pulse Biosciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 9.47M shares, a 24.60% decline from fiscal 2022.
  • Pulse Biosciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 12.55M shares, a 109.35% increase from fiscal 2021.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 7 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2026-06-3012.40M shares
10-Q · filed 2026-08-06
2026-03-3111.54M shares
10-Q · filed 2026-05-14
2025-12-3113.35M shares
10-K · filed 2026-02-19
2025-09-3013.51M shares
10-Q · filed 2025-11-05
2025-06-3013.75M shares
10-Q · filed 2026-08-06		13.72M shares
10-Q · filed 2025-08-12
2025-03-3113.73M shares
10-Q · filed 2026-05-14		13.70M shares
10-Q · filed 2025-05-08
2024-12-3112.51M shares
10-K · filed 2026-02-19		12.48M shares
10-K · filed 2025-03-31
2024-09-3018.19M shares
10-Q · filed 2025-11-05
2024-06-3011.60M shares
10-Q · filed 2025-08-12
2024-03-3110.10M shares
10-Q · filed 2025-05-08
2023-12-319.47M shares
10-K · filed 2025-03-31
2023-09-307.90M shares
10-Q · filed 2024-10-30
2023-06-306.89M shares
10-Q · filed 2024-08-19
2023-03-3112.82M shares
10-Q · filed 2024-05-07
2022-12-3112.55M shares
10-K · filed 2024-03-28
2022-09-3013.02M shares
10-Q · filed 2023-11-13
2022-06-3012.92M shares
10-Q · filed 2023-08-10
2022-03-315.56M shares
10-Q · filed 2023-05-11
2021-12-316.00M shares
10-K · filed 2023-03-31
2021-09-306.02M shares
10-Q · filed 2022-11-10
2021-06-305.92M shares
10-Q · filed 2022-08-10
2021-03-315.59M shares
10-Q · filed 2022-05-11
2020-12-315.76M shares
10-K · filed 2023-03-31
2020-09-306.04M shares
10-Q · filed 2021-11-15
2020-06-306.06M shares
10-Q · filed 2021-08-09
2020-03-314.28M shares
10-Q · filed 2021-05-10
2019-12-314.14M shares
10-K · filed 2022-03-31
2019-09-303.87M shares
10-Q · filed 2020-11-09
2019-06-303.50M shares
10-Q · filed 2020-08-10
2019-03-313.31M shares
10-Q · filed 2020-05-11
2018-12-313.39M shares
10-K · filed 2021-03-12
2018-09-303.29M shares
10-Q · filed 2019-11-07
2018-06-303.37M shares
10-Q · filed 2019-08-08
2018-03-313.08M shares
10-Q · filed 2019-05-03
2017-12-313.08M shares
10-K · filed 2020-03-16
2017-09-303.26M shares
10-Q · filed 2018-11-01
2017-06-303.09M shares
10-Q · filed 2018-07-31
2017-03-312.10M shares
10-Q · filed 2018-05-08
2016-12-312.10M shares
10-K · filed 2019-03-14
2016-09-302.13M shares
10-Q · filed 2017-11-08
2016-06-301.90M shares
10-Q · filed 2017-08-10
2016-03-311.25M shares
10-Q · filed 2017-05-10
2015-12-311.17M shares
10-K · filed 2018-03-16
2015-09-30959.43K shares
10-Q · filed 2016-11-14
2015-06-30690.51K shares
10-Q · filed 2016-08-10
2015-03-31677.90K shares
10-Q · filed 2016-06-27
2014-12-31299.63K shares
10-K · filed 2017-03-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
Heartflow, Inc. (HTFL)United States$4.225B
AtriCure, Inc. (ATRC)United States$3.089B
HAEMONETICS CORP (HAE)United States$4.821B36.52
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
NovoCure Ltd (NVCR)$1.886B-11.87
Advertisement